ZC 25 (Meloxicam 7.5 mg)
Pill with imprint ZC 25 is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Zydus Pharmaceuticals.
Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZC 25





Meloxicam
- Imprint
- ZC 25
- Strength
- 7.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
silicon dioxide,
trisodium citrate dihydrate,
povidone,
microcrystalline cellulose,
crospovidone
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
68382-0050 | Zydus Pharmaceuticals (USA) Inc. |
63739-0701 (Discontinued) | McKesson Packaging Services |
49999-0868 | Lake Erie Medical and Surgical Supply (repackager) |
More about meloxicam
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (549)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: Nonsteroidal anti-inflammatory drugs
Patient resources
- Drug Information
- Meloxicam (Advanced Reading)
- Meloxicam Intravenous (Advanced Reading)
- Meloxicam Orally-Disintegrating Tablets
- Meloxicam Capsules
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.